-       Report 
   - July 2024
    -  94 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                        Polymer Drug Conjugates (PDCs) are a type of pharmaceutical intermediate used to improve the delivery of drugs to target sites in the body. PDCs are composed of a drug molecule, a linker, and a polymer. The linker is used to attach the drug to the polymer, which helps to protect the drug from degradation and increases its solubility. The polymer also helps to target the drug to specific sites in the body, allowing for more efficient delivery.
PDCs have been used in the pharmaceutical industry for    many years, and their use is increasing due to their ability to improve drug delivery and reduce side effects. They are used in a variety of therapeutic areas, including cancer, infectious diseases, and cardiovascular diseases.
Some companies in the PDC market include PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTherics, PolyTher Show Less   Read more